Kymera Therapeutics (KYMR) Fofon Wukun
AI forecast: KYMR
AI akapichichin target price fowor next trading day, end of the week, ane end of the month. Change akapichichin fowor latest price. These are statistical estimates, not investment advice.
Price over the last 6 months
Premium e fannin na target-ka price ka AI an 1 raan, 1 uikku, 1 fawwun, fofon ane ekka fenn stock.
Unlock Premium🔒 Rekord faan faanik
Rekord fowkas past — fowkas past kato-in kato-in fowkas akis — akis akis Premium.
Unlock PremiumEttan An Company
Kymera Therapeutics, Inc. operates as a biopharmaceutical company focused on discovering and developing novel small-molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s natural protein degradation machinery. Kymera Therapeutics serves customers in Massachusetts.